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ABSTRACT
We reported previously that substitutions F61L,
F61W, F61Y and F61A in human immunodeficiency
virus type 1 (HIV-1) reverse transcriptase affect
strand displacement synthesis [T. S. Fisher,
T. Darden and V. R. Prasad (2003) J. Mol. Biol.,
325, 443–459]. We have now determined the effect of
these mutations on HIV replication. All mutant
viruses were replication defective. Measuring rep-
lication intermediates in infected cells did not reveal
a specific block as all mutants displayed reduced
DNA synthesis (wild-type.F61L.F61W.F61Y.
F61A). Analysis of 2-LTR circle junctions revealed
that F61W and F61Y mutants generated increased
aberrant circle junctions. Circle junctions corres-
ponding to F61Y included 30-PPT insertions sug-
gesting ribonuclease H defect. In vitro assays
mimicking PPT primer generation indicated that
F61L, F61W and F61Y mutant RTs were unaffected,
while F61A mutant cleaved both at PPT/U3 junction
and at 16 with similar efficiencies. In assays
measuring cleavage at the RNA/DNA junction to
remove the PPT primer, all mutants were signific-
antly affected with F61Y and F61A being most
severely impaired. Our results show that (i) replica-
tion block of most mutants is due to more than one
biochemical defect; (ii) mutations in polymerase
domain can affect the function of a distal domain;
and (iii) virological analyses of RT mutations can
yield insight into structure–function relationship
that is otherwise not obvious.
INTRODUCTION
Replication of human immunodeﬁciency virus type 1 (HIV-1)
genome involves conversion of its RNA genome into double-
stranded proviral DNA by the virion-associated RT (1). Viral
reverse transcription is initiated from the cellular tRNA
Lys,3
primer that binds near the 50 end of viral RNA at the primer-
binding site. DNA synthesis proceeds to the 50 end, forming
( ) strand strong stop DNA ( ssDNA). The RNA of newly
synthesized RNA–DNA hybrid is cleaved by the ribonuclease H
(RNase H) activity of RT, facilitating the transfer of
 ssDNA to the complementary region at the 30 end of the
genome RNA. Minus strand DNA synthesis is then contin-
ued. During this process, RNase H activity continues to
degrade RNA/DNA replication intermediate, with the excep-
tion of two short, polypurine tract (PPT) sequences located at
the center of the genome (cPPT) (2) and the 30 end of the gen-
ome (30PPT) (3). Plus strand DNA synthesis is primed from
these PPTs. At the 30 site, DNA synthesis continues until
RT copies a part of tRNA molecule, which is followed by
the second strand transfer and bidirectional DNA synthesis,
culminating in a linear double-stranded proviral DNA with
long terminal repeats (LTRs) (1).
HIV-1 RT, in addition to being a multifunctional enzyme
that can carry out RNA- and DNA-dependent DNA poly-
merase activities and the RNase H activity, can also support
strand displacement synthesis (4,5). Other retroviral RTs that
have been shown to be capable of strand displacement syn-
thesis include those of avian myeloblastosis virus (AMV)
(6,7), feline immunodeﬁciency virus (7) and Moloney murine
leukemia virus (8). Although accessory proteins, such as
Escherichia coli single-stranded DNA-binding protein, euka-
ryotic replication protein A (RP-A) and HIV-1 nucleocapsid
(NC) enhance strand displacement synthesis in vitro,R Ti s
capable of catalyzing strand displacement synthesis in their
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doi:10.1093/nar/gkl360absence (9–11). Two key steps in the viral life cycle involve
strand displacement synthesis. The ﬁrst of these occurs after
second strand transfer, when minus strand DNA forms a
circular intermediate via complementary sequences in the
primer-binding site region. Complete synthesis of the minus-
strand 50-LTR and linearization of the intermediate requires
that RT displaces  600 nt of DNA (1). Second, the formation
of central DNA ﬂap, a cis-determinant of HIV-1 nuclear
import, requires displacement of  100 nt near the center of
the proviral DNA (12,13).
Structure–function relationships of HIV RT are a subject of
intensive investigation both due to its central role in virus
replication and its importance as an antiviral target. Investiga-
tions to identify RT structural determinants of strand dis-
placement synthesis are lacking. One study investigating
interactions between RT and the duplex ahead of the active
site by DNase I footprinting (14) found that the non-template
strand is protected, at as far as 9 nt ahead of the catalytic cen-
ter. Using RT bound to a strand displacement substrate, the
2 bp immediately in front of the enzyme were found to be
melted (14). These ﬁndings suggest that RT plays an active
role in unpairing the DNA ahead of polymerase active site.
In a separate study from our laboratory previously, we
showed that residue F61 in the ﬁngers subdomain of HIV-1
RT p66 plays an important role in strand displacement syn-
thesis (15). Substituting F61 with Tyr or Leu increased the
efﬁciency of strand displacement synthesis, while a change
to Trp signiﬁcantly reduced this activity. These substitutions
also affected processivity of polymerization by RT, but the
changes in strand displacement synthesis did not correlate
to those in processivity. The crystal structure of a ternary
complex of HIV-1 RT (16) shows that F61 contacts a base
on the single-stranded template overhang immediately 50 of
the templating base. In order to gain mechanistic insight
into the role of F61 in strand displacement synthesis, a
5 bp duplex DNA was modeled, into the above structure,
ahead of the active site (15). In this model, F61 residue con-
tacts the terminal basepair of the duplex to be melted and sta-
bilizes it to a certain degree. Replacing F61 residue with other
amino acids in this structure revealed a negative correlation
between the ability of the amino acid at this position to sta-
bilize the terminal base pair and strand displacement syn-
thesis by the corresponding mutant RT. In other words,
substitutions with maximal stabilization, such as F61W led
to minimal strand displacement, while those that did not sta-
bilize the terminal base pair ahead of the active site were
maximally active in strand displacement synthesis (e.g.
F61L and F61Y). Thus, the F61 residue acts as a ‘switch’
to initiate melting of the duplex. Winshell et al. (17) have
examined the most severely affected mutant in this set,
F61W, for its effect on the melting of the +2 and +3 using
the permanganate sensitivity assay. Those studies indeed con-
ﬁrm that F61W mutant is deﬁcient in melting the two bases
ahead of the active site (17).
In the present study, we have investigated the effect of sub-
stitutions F61L, F61W, F61Y and F61A on HIV replication.
Our results indicate that all F61 mutant viruses are replication
defective. Interestingly, the relative degrees of replication
defects did not directly correlate to effects of the mutations
on in vitro polymerase function of RT. Thus, the replication
block in F61 substitution mutants appears to be due to
additional defects in other steps of viral replication. Since
the formation of 50-LTR is accomplished via strand displace-
ment synthesis, we analyzed 2-LTR circle junctions, as sur-
rogate for linear viral DNA, from cells infected with the
wild-type, F61L, F61W and F61Y mutants. This analysis
revealed that the defects in strand displacement synthesis
were partly commensurate with replication defects, but also
suggested that some mutants may be defective for PPT primer
removal. In vitro studies were performed to evaluate whether
recombinant mutant RTs display RNase H defects, which
showed that F61Y RT was indeed defective in RNase
H-mediated removal of PPT RNA from plus DNA, while
F61A was defective for both the generation of PPT RNA pri-
mer and its removal. Thus, mutations at F61, a residue con-
tacting the incoming template strand, appear to disrupt viral
replication not only due to defects in the polymerase domain
function, but also in the function of the distally located RNase
H domain.
MATERIALS AND METHODS
Plasmids
Mutations were introduced at the F61 residue in the HIV-1
RT of HxB2 full-length molecular clone (R3B) via cassette
mutagenesis (18). In short, an intermediate molecular clone
was constructed by ligating a 4.2 kb SpeI/SalI fragment span-
ning gag p24 to integrase of HIV-1 (nt 1560–5720) into
pBSKS(+) vector. Using the intermediate clone as template,
a 1.2 kb upstream fragment was ampliﬁed with the primers
‘BS Forward’ (50-TGTAAAACGACGGCCAGTGAG-30)
and ‘F61BsmB-1’ (50-CTGCAGCGTCTCCTGGAGTATTG-
TATGGAT-30). Similarly a downstream 3.0 kb fragment was
ampliﬁed using the primers ‘BS Reverse’ (50-GGAAACA-
GCTATGACCATGAT-30) and ‘F61BsmB-2’ (50-CTGCA-
GCGTCTCAGAACTTAATAAGAGAAC-30). PCR products
were digested with SpeI and PstI or SalI and PstI, respect-
ively, and the fragments cloned into SpeI and SalI sites of
plasmid pBSKS(+) via a 3-piece ligation, to generate a cas-
sette acceptor plasmid. The cassette acceptor clone was
sequenced to conﬁrm the absence of undesired mutations,
digested with BsmBI, a type II restriction enzyme followed
by ligation of double-stranded adapters containing desired
mutant sequences for F61 (19). The 4.2 kb SpeI to SalI frag-
ments from the intermediate clones with each of the F61 sub-
stitutions were cloned between the SpeI and SalI sites of
HIV-1R3B molecular clone.
Oligodeoxyribonucleotides and oligoribonucleotides
A 40 nt oligomer containing the (+) strand DNA of HIV-1
PPT was purchased from Integrated DNA Technology
(Coralville, IA). A complementary 30 nt RNA containing
the HIV-1 30 PPT and a 20 nt chimera containing 15 nt
PPT RNA and 5 nt DNA from the ﬂanking U3 sequence was
purchased from Dharmacon Research (Boulder, CO). Oligo-
nucleotides were puriﬁed by preparative PAGE and quanti-
ﬁed spectrophotometrically (260 nm), assuming a molar
extinction coefﬁcient equal to the sum of the constituent
deoxynucleotides. Hybrids were prepared by heating a 1.5:1
RNA–DNA mixture to 95 C in 10 mM Tris–HCl, pH 7.8,
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Samples were stored at  20 C.
Viruses
Mutant viruses were generated by transfecting full-length
molecular clones into 293T cells. The 293T cells were main-
tained in DMEM containing 10% fetal bovine serum (FBS).
Ten micrograms each of wild-type (HIV-1R3B) and F61 mut-
ant DNA were used. Transfection was via CaPO4 procedure
(Specialty Media, Phillipsburg, NJ). Ten 100 mm dishes con-
taining  50% conﬂuent 293T cells were transfected with
10 mg DNA/plate of the molecular clones of wild-type or
F61 mutants. Twenty-four hours after transfection, super-
natants were collected, ﬁltered through 0.45 mm ﬁlter (Costar,
Corning, NY) and virus particles in the supernatant concen-
trated by sucrose density centrifugation using 20% sucrose.
After centrifugation, the virus pellet was washed once with
phosphate-buffered saline (PBS) carefully and re-suspended
in PBS.
Determination of virus production and infectivity assay
Virus production after transfection was monitored by Gag
p24 production using a commercially available kit (Perkin-
Elmer, Boston, MA). To quantitate the infectivity of wild-
type and mutant virus particles, reporter cells with lentiviral
tat-driven expression of luciferase [CEM-LuSIV cells (20)]
or b-galactosidase [P4-HeLa cells (21)] were used. Equal
amounts of viruses (50 ng of p24) were used to infect
CEM-LuSIV cells. Twenty-four hours after infection, cell
lysates were assayed for luciferase activity (Promega, Mad-
ison, WI), measuring the output expressed as relative light
units (RLUs) on a luminometer. P4-HeLa reporter cells,
which contain an integrated copy of HIV LTR-driven
LacZ gene, were used to calculate the viral titer as follows.
Wild-type and F61 mutant viruses equivalent to 10 ng of
p24 were used to infect P4-HeLa cells and 36 h post-
infection, cells were ﬁxed in 0.1% glutaraldehyde and stained
with X-Gal (5-bromo-4-chloro-3-indolyl-b-D-galactopyranos-
ide) to detect cells that displayed HIV infection-mediated
activation of the b-galactosidase gene.
Western blot analysis of virion proteins
Virus supernatants of wild-type and F61 mutants each con-
taining equivalent amounts of Gag p24 ( 50 ng) were separ-
ately mixed with 0.5 ml 30% PEG containing 0.4 M NaCl to
a ﬁnal volume of 1.5 ml. The mixture was incubated over-
night at 4 C and then centrifuged at 4 C for 45 min at
8000 r.p.m. (6800 g). The virus pellet was washed with PBS
once and lysed in virus lysis buffer (50 mM Tris–HCl, pH
7.4, 100 mM DTT, 50 mM KCl, 0.025 Triton X-100 and
2% SDS). The lysate was analyzed for virion proteins by elec-
trophoresis through a 4–20% gradient SDS–polyacrylamide
gel overnight at 50 V. Proteins were transferred to nitrocellu-
lose membrane in a trans-blot apparatus (Bio-Rad) and detec-
ted by immunoblotting using HIV-1-positive human sera
(obtained through the NIH AIDS Research and Reference
Reagent Program, Division of AIDS, NIAID, NIH: HIV-IG
from NABI and NHLBI) as primary antibodies and horseradish
peroxide-conjugated goat anti-human IgG as secondary anti-
bodies. Finally, the antibody-reactive proteins were
visualized by chemiluminisence using Luminol substrate
(Perkin Elmer).
Multi-day replication assay
Jurkat cells were infected with wild-type and mutant viruses
at similar virus-to-cell ratios (10 ng p24). Infection was car-
ried out in 2 ml of serum-free RPMI media for 2 h at 37 C.
After 2 h incubation, cells were centrifuged, washed with
PBS and re-suspended in 10% FBS containing media. An
aliquot of supernatant was collected from wild-type and
F61 mutant virus cultures at 4-day intervals and preserved
in presence of 1% Triton X-100. Gag p24 was measured as
described above.
Real-time PCR quantification of reverse transcription
intermediates
The speciﬁc DNA copy numbers of reverse transcription
intermediates synthesized within the wild-type and F61 mut-
ant virus-infected cells were measured by real-time PCR as
described previously (22) using Taqman technology (Applied
Biosystems). The primers and probes speciﬁc for ( ) strand
ssDNA, Gag full-length genome and 2-LTR circles were as
described previously (22,23). Real-time PCR was performed
on an ABI7700 apparatus (Applied Biosystems) in a ﬁnal vol-
ume of 35 ml. Jurkat cells were infected with 60 ng (p24) each
of wild-type and F61 mutant viruses over a period of 2 h in
serum-free medium. To each well, DNase I (10 U/ml) was
added (to remove carry-over viral DNA added in transfec-
tion) in presence of 10 mg/ml MgCl2 and the cells were
incubated for another 30 min at 37 C. Cells were washed
in PBS and re-suspended in fresh media containing FBS.
After 2, 24 and 48 h, respectively, cells were harvested and
total DNA was isolated using Qiagen DNeasy tissue kit (Qia-
gen). Approximately 500 ng DNA was used for each PCR.
Plasmid DNA of molecular clone, HIV-1R3B, was used as ref-
erence DNA to prepare a standard curve. For the standard
curve of 2-LTR circles, the 2-LTR junction sequence was
PCR ampliﬁed from wild-type HIV-infected Jurkat cells
and the PCR product cloned into the TA cloning vector
pCR 2.1 (Invitrogen) to generate p2-LTR. The sequence of
the clone was veriﬁed using the published sequence for
HIV-1HXB2. Dilutions of this plasmid were used to generate
standard curve for 2-LTR circle DNA.
Analysis of 2-LTR circle junction sequences
The 2-LTR circle junctions were PCR ampliﬁed from wild-
type and F61 mutant virus-infected Jurkat cells. Forty-eight
hours post-infection, cells were washed twice with PBS and
the total DNA isolated from cells using a Qiagen DNeasy tis-
sue kit following manufacturer’s protocol. Circle junction
sequences were PCR ampliﬁed by a two-step nested PCR
using 2-LTR circle junction speciﬁc primers as described
by Julias et al. (22). The PCR products were analyzed on
an agarose gel to detect the expected 200 bp fragment, and
subsequently cloned into a TA cloning vector according to
the manufacturer’s protocol. Sequence determination for an
average of 25 clones for wild-type and each F61 mutant
was performed. Statistical analysis was performed with the
2-LTR circle junction sequences to determine the signiﬁcance
of differences. The data were analyzed by contingency table
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with traditional two-by-two Fisher’s exact tests.
RNase H assays
PPT selection was evaluated using recombinant wild-type
and F61 mutant HIV-1 RT and the previously described
RNA/DNA hybrids. 50-End-labeling of the PPT-containing
30mer RNA or 20mer RNA–DNA chimera was performed
with T4 polynucleotide kinase and [g-
32P]ATP. Substrates
were generated by annealing the radiolabeled PPT-containing
RNA oligomer or RNA–DNA chimera to the 40 nt DNA.
Hydrolysis was initiated by adding the wild-type or mutant
enzymes to the hybrids in 50 mM Tris–HCl (pH 7.8),
50 mM NaCl, 5 mM DTT and 5 mM MgCl2 at 37 C, with
enzyme and substrate present at ﬁnal concentrations of
15 and 50 nM, respectively. Reactions were terminated at
times speciﬁed, by adding an equal volume of a formamide-
based gel-loading buffer [95% (v/v) formamide containing
0.1% (w/v) bromophenol blue and xylene cyanol], and the
hydrolysis products fractionated by high-voltage electrophor-
esis through 15% (w/v) polyacrylamide gels containing 7 M
urea. Products were visualized by autoradiography and/or
phosphorimaging and quantiﬁed using Quantity One software
(Bio-Rad).
RESULTS
The effect of F61 mutations on viral replication
In order to evaluate the inﬂuence of F61 substitutions (F61L,
F61W, F61Y and F61A) on HIV replication, molecular
clones bearing these mutations were constructed to generate
virus particles. At 24 h post transfection, Gag p24 was meas-
ured in the supernatants of 293T cells transfected with these
clones. Virus production by all F61 mutants was comparable
to wild type (data not shown). In order to examine the effect
of F61 mutation on maturation and assembly of virion pro-
teins, lysates were subjected to immunoblot analysis. No
qualitative differences in the virion protein proﬁles between
the wild-type and the F61 mutant viruses were observed.
Mutant virion particles contained correctly sized Gag p24,
p66 and p51 RT proteins (Figure 1). These results indicate
that F61 substitutions do not affect virion production and
viral protein assembly steps of HIV replication.
In order to delineate defects in early replication events, the
infectivity of wild-type and F61 mutant viruses was assayed
on CEM-LuSIV cells, containing the LTR-luciferase reporter,
and Hela-P4 cells containing LTR-b-gal reporter genes. The
luciferase and b-galactosidase proteins are induced by the
newly synthesized HIV-1 Tat protein upon infection with
HIV-1. All F61 mutant viruses displayed reduced infectivity
on both LuSIV and Hela-P4 cells. The infectivity of F61 mut-
ant viruses, as assayed on LuSIV cells are shown in
Figure 2A. F61A virus was non-infectious, while the infectiv-
ity of F61L, F61W and F61Y were 8.5, 2.5 and 0.6% that of
wild type (Figure 2A). Our results suggest that the F61 mut-
ant viruses have defect(s) in one or more steps during viral
replication including reverse transcription, nuclear transport,
integration or expression.
We next studied the replication kinetics of wild-type and
F61 mutant viruses by infecting Jurkat T cells with equal
amounts (10 ng p24) of wild-type and F61 mutant viruses.
We measured p24 in the supernatants collected at 4-day inter-
vals over a period of 20 days, which showed that each of the
F61 mutant viruses was unable to replicate as efﬁciently as
wild-type virus. No p24 protein was detected in the culture
supernatants of F61A and F61Y viruses. Highest p24 produc-
tion by wild-type virus was observed at day 8. At day 8, the
average p24 value of wild type was 1040 ng/ml and F61L and
F61W produced only 72 and 10 ng/ml of p24 (Figure 2B and
inset within this ﬁgure). Both F61A and F61Y failed to pro-
duce any detectable amounts of p24 protein. Among the four
F61 mutants, F61L displayed some replication capability
although it was at least 14 times less than the wild type
(Figure 2B) at peak level. F61W was also replication defect-
ive with very low amount of p24 production through 20 days.
The slow replication of F61W mutant is in partial agreement
with a previous study, in which the F61W mutant virus dis-
played delayed replication kinetics (24).
Analysis of intracellular reverse transcription
to detect specific blocks
It was of interest to deﬁne the speciﬁc step in viral replication
that is affected by the F61 mutations. The progress of retro-
viral reverse transcription process can be monitored via PCR
using primers designed to detect speciﬁc replication interme-
diates. In order to quantify the intermediates synthesized by
wild-type and F61 mutants, we carried out real-time PCR at
2, 24 and 48 h post infection, using primers and probes spe-
ciﬁc for (i) the  ssDNA (early reverse transcription), which
p66
p51
p41
(MA+CA)
p24
p17
  C1                        C2     WT   F61A   F61L   F61W  F61Y
Figure 1. Analysis of wild-type and F61 mutant virion proteins. Virion
proteins were isolated from wild-type and mutant viruses and resolved by
electrophoresis through a 4–20% gradient SDS–polyacrylamide gel. Proteins
were immunoblotted with anti-HIV antiserum (NIH AIDS Reference Reagent
Program). Lanes C1 and C2 refer to positive controls, recombinant HIV-1 RT
(heterodimeric with p66 and p51 bands) and p24, respectively.
2856 Nucleic Acids Research, 2006, Vol. 34, No. 10is the earliest product of reverse transcription; (ii) gag
sequences, which signify the production of full-length viral
DNA (late reverse transcription); and (iii) the 2-LTR circle
DNA, which indicates nuclear import of synthesized DNA.
Both early and late RT products formed by the F61 mutant
viruses were reduced compared with wild-type virus at the
time points tested (Figure 3). With respect to reverse tran-
scription intermediates, no particular step appeared to be spe-
ciﬁcally affected. Rather, there was a general reduction in the
viral DNA synthesis at all steps. The efﬁciency of  ssDNA
DNA synthesis was in the order of wild-type>F61L>F61W>
F61Y>F61A. However, all mutant viruses displayed consist-
ent increase in  ssDNA synthesis from 2 to 24 h post infec-
tion (Figure 3). The F61 mutant viruses were also unable to
synthesize late RT products as efﬁciently as wild type. At
2 h post infection, F61W was able to synthesize late RT pro-
ducts as efﬁciently as F61L. Similar to the  ssDNA, the
amount of gag DNA synthesis increased from 2 to 24 h for
wild-type, F61L, F61W and F61Y (Figure 3) whereas F61A
failed to synthesize signiﬁcant amount late RT products
even at 24 h.
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Figure 3. Real-time PCR quantification of reverse transcription products
synthesized by wild-type and F61 mutant viruses in Jurkat cells at 2, 24 and
48 h. DNA copy number was quantified per 500 ng of infected cellular DNA.
(A) Copy number of early reverse transcription product (R-U5). (B) DNA
copy number of late reverse transcription products (gag). (C) Copy numbers
of 2-LTR circle DNA.
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Figure 2. (A) Infectivity of wild-type and F61 mutant viruses. RLUs are
obtained in duplicate and presented with error bars. (B) Replication kinetics
of wild-type and F61 mutant HIV-1 viruses. Jurkat cells were infected with
equal amounts of wild-type and F61 viruses, cultures maintained for 20 days
and the amount of p24 produced in the supernatant measured at 4-day
intervals. The inset graph depicts the data for mutant viruses alone for clarity.
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the F61 mutant virus-infected cells at 2 h post infection.
For wild-type virus, this is consistent with the fact that nuc-
lear import of reverse transcription intermediates is a late
event. However, for mutants F61L and F61W, just as in the
case of  ssDNA and gag DNA intermediates, the level of
2-LTR circle DNA was lower than wild type at 24 and 48 h
post-infection, while F61A and F61Y mutants failed to
make any 2-LTR circle DNA (Figure 3). At 24 h post-
infection, the copy number of 2-LTR circle DNA synthesized
by wild type was 95, which is  5 times higher than F61L and
 16 times more than that of F61W. The amount of 2-LTR
circle DNA formed by wild type, F61L and F61W increased
from 24 to 48 h (Figure 3), though the level of increase was
much higher for wild type. At 48 h post infection, wild-type
virus was able to form 2-LTR circle DNA  10 and  27
times higher than F61L and F61W, respectively.
Sequence analysis of 2-LTR circle junction
In order to evaluate the extent of strand displacement syn-
thesis, we directly analyzed the structure of strand displace-
ment product (50-LTR) synthesized during viral DNA
synthesis in cells infected by F61 mutant viruses. After nuc-
lear transport, a low, but signiﬁcant proportion of the linear
viral DNA is circularized. Thus, it is possible to gain an
insight into the structure of both termini of the linear DNA
by sequencing 2-LTR circle junctions.
We PCR ampliﬁed a 188 bp fragment around the U5–U3
junction from cells infected with wild-type, F61L, F61W
and F61Y mutant viruses. A nested PCR approach allowed
us to obtain products even from F61Y virus infected cells
(where real-time PCR did not detect any products), but we
were unable to recover any sequences for F61A mutant.
Ampliﬁed DNA was cloned and  25 clones each for wild-
type, F61L, F61W and F61Y mutant viruses were sequenced.
The sequences were aligned and their LTR structures are
depicted in Figure 4 (sequences themselves are included in
Supplementary Data). Analysis of wild-type virus revealed
that  40% of the clones contained the consensus 2-LTR
junction sequence. A majority of the remaining sequences
have either large (>100 bp) or small deletions. One sequence
contained a 31 bp insertion, corresponds to the PPT and its
50-ﬂanking sequence (Figure 4). Among the mutants, F61L
virus produced sequences with a distribution similar to wild
type, with close to 50% consensus sequences. For F61W
mutant virus, 40% of the sequences had either large or partial
deletions (Figure 4). Seven sequences had a unique deletion at
the U3 region (25%, P < 0.02). Interestingly, all 26 F61Y
sequences had a unique 9 base insertion of ‘TTAGGGGGG’
sequence (P < 0.001; Figure 4), which corresponds, in part,
to an unprocessed segment of PPT primer. The presence of
only one species of sequences with unprocessed PPT suggests
that the F61Y RT may be defective in its ability to remove the
PPT primer RNA (also see Discussion).
Ability of F61 mutants to generate PPT primer and
its removal from plus DNA
Virological analysis described above suggested a possible
defect in the ability of F61Y RT-associated RNase H to
efﬁciently remove the PPT primer from plus strand DNA.
Retroviral RNase H is involved in two speciﬁc steps during
initiation of plus strand DNA synthesis. First, following
minus strand DNA synthesis across the PPT sequence,
RNase H activity cleaves at the 30 terminus, thereby provid-
ing a primer for plus strand, DNA-dependent DNA synthesis.
Second, subsequent to the initiation of plus strand DNA syn-
thesis the PPT RNA is removed by a cleavage at the RNA–
DNA boundary. We ﬁrst examined the wild-type and F61
mutant RTs for their ability to cleave a PPT-containing
30 nt oligoribonucleotide annealed to DNA. The results
show that mutants F61L, F61W and F61Y display mild
reductions in cleavage at position  1 (Figure 5A and B and
Table 1) with efﬁciencies of cleavage being 77, 68 and 50%
of wild type (at 3 min). The F61A RT mutant was most
compromised with 6% cleavage efﬁciency compared to
wild-type HIV-1 RT. Interestingly, F61A mutant also dis-
played enhanced cleavage at +6 position of the U3. Using
30 end-labeled substrates, we showed previously that PPT-
containing RNA/DNA hybrids were cleaved at the PPT/U3
junction and position +6 with almost equal efﬁciency (25).
In keeping with data from Champoux and co-workers (26),
this dual cleavage event and dissociation of the resulting
hexanucleotide has been proposed as a means of providing
a short single-stranded template overhang to assist initiation
of plus strand DNA synthesis.
We next tested the ability of wild-type and mutant RTs to
cleave at the same site, but this time using substrate with a
PPT-containing RNA/DNA hybrid at the PPT/U3 junction
(deﬁned as position  1 in Figure 5A). Cleavage at the
RNA–DNA junction in this substrate mimics removal of
the PPT primer from nascent plus strand DNA to create prop-
erly processed U3 LTR terminus. Figure 5D shows a time
course of the cleavage reactions using this substrate. Correct
cleavage to remove the PPT primer occurs at the RNA/DNA
junction as shown (Figure 5D, wild type). Mutants F61L,
F61W and F61Y all show signiﬁcant cleavage at this position,
but are reduced 5- to 10-fold compared with wild-type levels.
Of these three RT mutants, F61Y indeed shows the lowest
level of cleavage, while F61A appears to be severely com-
promised (Figure 5D and Table 1).
DISCUSSION
We have examined the inﬂuence of F61 substitution muta-
tions (19), shown previously to affect strand displacement
synthesis (15,17) on viral replication. None of the mutants
tested (F61L, F61W, F61Y and F61A) showed speciﬁc
defects in the assembly (Figure 1) or production of virion par-
ticles (data not shown). All F61 mutants were compromised
for infectivity. Experiments to measure virus spread showed
that mutant viruses were defective in the order of wild-
type>F61L>F61W>F61Y>F61A. Attempts to identify spe-
ciﬁc blocks to virus replication, using real-time PCR to meas-
ure reverse transcription intermediates, revealed decreased
levels of both early and late reverse transcription products,
which appeared to reﬂect a generalized defect in DNA rep-
lication process rather than a speciﬁc block in strand displace-
ment synthesis.
Our previous in vitro biochemical studies with F61-
substituted recombinant RT mutants provided a valuable
2858 Nucleic Acids Research, 2006, Vol. 34, No. 10yardstick to understand the viral replication defects (19).
However, it must be pointed out that those studies employed
subunit-selective mutagenesis such that only the p66 subunit
contained the substitution, while the p51 was wild type. For
site-directed mutations that are not found in the clinical isol-
ates, p66-selective mutagenesis is the preferred approach as it
minimizes possible heterodimer instability via the mutation in
the p51 subunit. Viruses employed here, however, contained
RT heterodimers with the mutation on both subunits. We feel
that the virological effects obtained do not indicate dimeriza-
tion defects, although some effect on heterodimer stability
cannot be ruled out.
The extent of intracellular reverse transcription correlated
well with infectivity and replication capacity of mutant vir-
uses (Table 1 and Figure 2). Quantitative data on the intracel-
lular reverse transcription also provided us an opportunity to
compare it with our previous in vitro studies on RT function
(15,19). Those studies showed that recombinant RTs with
substitutions F61L, F61W and F61Y displayed wild type or
higher levels of RNA-dependent DNA polymerase activity,
while F61A RT displayed a decrease. In addition, the
F61Y, F61L and F61A RTs exhibited lowered processivity
(in that order) while F61W mutant RT displayed higher pro-
cessivity compared with wild type (15). On the other hand,
the F61L and F61Y mutant RTs had much higher strand dis-
placement activity than wild-type RT in vitro. Thus, it is
understandable that despite a lower processivity of RT mutant
F61L (15) (Table 1), the generally more robust RT activity
including strand displacement synthesis may support efﬁcient
elongation during viral DNA synthesis, permitting a basal
virus replication and a minimally affected intracellular viral
DNA synthesis. Thus, it appears that despite the lowest pro-
cessivity of all the mutants and a 5-fold reduction in one of
the RNase H activities tested (PPT-primer removal) com-
pared to wild type, the F61L virus displayed the highest rep-
lication capacity among the mutant viruses. This is interesting
considering the fact that F61L is less processive than F61W.
F61W RT displayed enhanced in vitro RT activity and
 
 
 
 
Figure 4. Summary of 2-LTR circle junction sequences from cells infected with wild-type or F61 mutant viruses. The 2-LTR circle junctions are generated by
ligation of the LTR ends of full-length linear viral DNA as shown on the top left. The canonical, simple ligation of the 2-LTRs is labeled ‘consensus’ and shown
at the top, followed by the various non-canonical forms due to improper cleavage of one of the primers, incomplete strand displacement synthesis or other causes
as listed next to each diagram. PPT insertions are represented as solid lines, sequences from upstream of PPT as square dots, tRNA insertions as dots and
deletions within the U5 or U3 as gray boxes. The fraction of each type of 2-LTR circle junction generated by wild-type and F61 mutant viruses are presented in
the table. The box at the bottom lists the percentage of intact, fully formed U3 sequences for each virus.
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lowest in vitro strand displacement synthesis of all mutants
studied (Table 1). In fact, F61W appears to be similar to
F61L in all respects except for its lowered strand displace-
ment activity (Table 1). Among the four F61 mutant viruses
studied, the F61A mutant was the least infectious, replication-
defective and produced the lowest level of viral DNA and
no 2-LTR circles (Figure 3). Though F61A RT had a near
wild-type-like strand displacement activity, the processivity
of this enzyme was severely reduced (Table 1). Thus, the rep-
lication defect of F61A virus appeared to be a combination of
lower enzymatic activity and processivity. F61Y RT dis-
played in vitro polymerase and strand displacement synthesis
properties exceeding those of wild-type RT and near wild-
type processivity on both RNA and DNA templates. Thus,
impairment of intracellular viral DNA synthesis by the
Figure 5. RNase H-mediated Polypurine tract selection. (A) Sequences of the oligonucleotides in the RNase H substrate for the generation of PPT primer. A
30mer plus RNA annealed to a 39mer plus DNA strand is shown. The major RNase cleavage at  1 is depicted by an arrow. Template numbering defines +5a s
the fifth nucleotide downstream of the 30 end of PPT. Numbering defines  1 as the last nucleotide of PPT RNA. RNA sequence is shown in lowercase letters and
DNA sequence in uppercase. (B) RNase H cleavage profile of PPT/U3 RNA/DNA substrate by wild-type and F61 mutant RTs. The 50 end labeled RNA/DNA
hybrid substrates were incubated with wild type or each of F61 mutant RTs and RNase mediated hydrolysis was carried out for specified times. Hydrolysisb y
wild-type or F61 mutant RTs are indicated. Lanes P, a, b, c, d and e correspond to 0, 1, 3, 5, 7 and 10 min, respectively. Hydrolysis products were fractionated
through 15% (w/v) polyacrylamide gels and visualized by phosphorimaging. Bands resulting from cleavages at PPT/U3 junction and +6 position are indicated on
the left and right sides of panel. (C) A 20mer chimeric oligonucleotide containing 15mer PPT RNA attached to a pentameric oligodeoxynucleotide is annealed to
39mer minus DNA strand. (D) Hydrolysis pattern of a PPT/U3 specific RNA/ RNA–DNA chimera by wild-type and F61 mutant RTs. Time points for RNase-
mediated cleavage are indicated. Lanes P, a, b, c, d and e correspond to 0, 1, 3, 5, 7 and 10 min, respectively. Cleavage products were analyzed as described
above. Specific cleavages at U3/PPT junctions are indicated by arrows.
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polymerase activities of F61Y mutant RT.
After completion of viral DNA synthesis in the cytoplasm,
double-stranded viral DNA is imported to the nucleus, where
it is integrated into the host chromosome. Unintegrated viral
DNA is circularized through a variety of mechanisms (27).
One form is the 2-LTR circle, which results from ligation
of LTR ends of linear viral DNA. Sequence analysis of
2-LTR circle junctions, as a surrogate to determine the state
of the unintegrated linear DNAs, provides valuable informa-
tion on steps such as initiation of plus strand DNA synthesis,
incomplete LTR formation due to impaired strand displace-
ment synthesis and removal of tRNA or PPT primers (28).
However, two caveats must ﬁrst be recognized. The 2-LTR
circles represent a by-product rather than an intermediate
for the next step, integration. Second, the pool of 2-LTR
circles is likely enriched for molecules that failed to proceed
to a successful integration event. Despite these caveats, the
2-LTR circles constitute a reasonable sample of the total
viral DNA synthesized and yield useful information on the
status of the linear DNA precursor population. Intact U3
termini in the 2-LTR circle junctions suggest completion of
strand displacement synthesis. However, deletions at the U3
termini tend to be a combination of both incomplete strand
displacement and incomplete plus strand primer removal.
Incomplete removal of the PPT or tRNA primer can result
in single-stranded termini in the linear DNA, which trigger
nucleolytic removal due to their longer half-lives (1). Despite
using nested PCR, we failed to recover 2-LTR circle junc-
tions from cells infected with F61A mutant virus, consistent
with the absence of 2-LTR circles in the real-time PCR ana-
lysis (Figure 4). In contrast, circle junction sequences were
recovered with mutant F61Y, which also did not show any
2-LTR circles in that analysis.
Analysis of a larger number of circle junction sequences
reveals signiﬁcant diversity in the types of sequences ampli-
ﬁed, thus assuring that the products analyzed do not represent
ampliﬁcation of a single species. Our study shows that
sequence distribution of 2-LTR circle junctions generated
by wild-type virus is in agreement with the previous reports
by other groups (24,28,29). The distribution of 2-LTR circles
formed by the F61L mutant virus was largely similar to
that of wild-type, while that of F61W and F61Y mutant
viruses differed. Although F61W mutant displayed a similar
proportion of consensus sequences (0.36 for F61W versus
0.39 for wild type), seven of 28 sequences (0.25) contained
a unique U3 deletion and insertion of the PPT and ﬂanking
sequences (Figure 4). This suggests both incomplete strand
displacement synthesis and incomplete removal of the PPT
primer. The fact that F61Y virus produced very few 2-LTR
circles that could not be detected by real-time PCR suggests
that the sequences recovered by nested PCR are ampliﬁcation
of a rare event or represent multiple, identical events. In any
event, the prevalence of PPT sequences suggests inefﬁcient
removal of the plus strand primer. Although the distal posi-
tioning of F61 to RNase H does not immediately suggest
the inﬂuence of F61 mutations on that activity, we have stud-
ied the effect of these mutations on PPT removal using
recombinant puriﬁed RTs in vitro.
The results of in vitro RNase H PPT-primer generation and
primer removal assays showed that F61Y is indeed defective
for PPT removal with one of lowest levels among F61
mutants (9% of wild type, Figure 5D and Table 1). Further-
more, the results of the RNase H assays highlight the follow-
ing features: (i) mutating a residue that contacts the template
50-overhang can affect the activity of a distal domain such as
RNase H with an active site located  18 bp along the
template–primer duplex; (ii) F61A RT is defective both in
the efﬁciency and speciﬁcity of cleavage at the PPT/U3
RNA junction during generation of the PPT primer, while
the ability to cleave at the PPT/U3 junction is abrogated.
The RNase H defect cumulatively with other in vitro defects,
explains the rather severe defect of this mutant; and
(iii) F61Y RT is mildly affected for PPT/U3 RNA cleavage,
but shows reduced cleavage at PPT/U3 RNA–DNA junction,
which correlates with virological results from the 2-LTR
junction sequence analysis. These results provided new
insight into an additional defect of F61Y mutant that appears
to have contributed to its severe replication defect.
‘Long-range’ effects of polymerase domain mutations
such as F61Y and F61A are not without precedent and
have been well documented. For example, several insertion
mutations in the polymerase domain of HIV-1 RT had mild
to severe effects on RNase H activity (30–32). Furthermore,
site-directed mutations have demonstrated that (i) mutating
W232 of the DNA polymerase primer grip (33) or deletion
of a 13-residue C-terminal deletion of the non-catalytic
p51 subunit (34) can modulate RNase H activity and
Table 1. The influence of F61 mutations on various enzymatic and virological functions
Enzyme RDDP
activity
a
DDDP
activity
a
Processivity
b
(DDDP and
RDDP)
S.D.
30-PPT
b
Percent
normal 2-LTR
junctions
c
RNase H PPT
primer
generation
d (%)
RNase
H PPT primer
removal
e (%)
Infectivity
f
(percent WT)
Intracellular
reverse
transcription
g
WT + + +++ + 40% (n ¼ 23) 100 100 100 20300
F61L ++/++ + + + + 50% (n ¼ 22) 77 20 8.5 5840
F61W +++ +++ ++++ +/  35% (n ¼ 28) 68 19 2.5 1150
F61Y ++++ +++ ++ ++ 0% (n ¼ 26) 50 9 0.6 238
F61A ++ /  +/  + ND 6 3 ND 17
aData from Fisher and Prasad (19).
bData on strand displacement synthesis (S.D.) using 30-PPT substrate from Fisher et al. (15).
cData from the results described in Figure 4.
dData from results presented in Figure 5B. Numbers correspond to  1 cleavage.
eData from results presented in Figure 5D.
fData from the results described in Figure 2.
gNo. of copies of Gag-full-length DNA at 24 h from the real-time PCR results described in Figure 3.
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interactions, can alter both the efﬁciency and speciﬁcity of
RNase H cleavage (35). Such insights have also been
obtained previously with other RT mutations. For example,
Julias et al. (36) analyzed the 2-LTR circles from M184V
and M184T mutant viruses. Although M184V mutant
sequences were largely similar to those of wild type, the
M184T mutant sequences included those with the insertion
of tRNA in the 2-LTR junctions. This suggested a defect in
the RNase H function caused by the M184T mutation.
Our results show that most F61 substitutions lead to defects
in viral replication not only due to their effects on strand dis-
placement, but also due to causes such as defects in elonga-
tion (F61L) and the efﬁciency and speciﬁcity of RNase H
cleavages at the PPT (F61Y and F61A). We speculate that
altering the contact near the template 50-overhang can affect
RNase H cleavage speciﬁcity due to a role for F61-template
contact in repositioning of the enzyme during RNase H cleav-
age. The F61 mutations also appeared to exert their inﬂuence
on viral replication partly due to a generalized reverse tran-
scription defect that could not be predicted from the
in vitro behavior of the mutant enzymes. As mentioned
before, we do not believe that this early defect is due to an
elongation defect caused by heterodimer instability. Other
possible causes for an early defect could be potentially in
the interaction with nucleocapsid protein or Integrase, both
of which have been shown to interact with HIV-1 RT
(37,38). In fact, the Integrase-interaction domain on HIV-1
RT has been mapped on to ﬁngers-palm domains. Additional
studies are needed to pinpoint the early defect of these
mutants. The F61W mutant appears to suffer partly due to
a strand displacement synthesis defect (as shown by greater
U3 deletions and insertion of PPT sequences) since it appears
equal in all other respects to F61L, which replicates much
better.
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